Trial results

$GPCR — ACCG-2671

Structure Therapeutics Inc. (GPCR) ACCG-2671: trial results in Obesity, 2027.

Research by Catalyst Intel

The catalyst

"Topline data for the MAD portion of the Phase 1/2a clinical trial are expected in the first half of 2027."

— Structure Therapeutics Inc., 8-K filed 2026-09-08 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

GPCR-ACCG2671-2026

Company

Structure Therapeutics Inc.

Kind

Trial results

Indication

Obesity

Window

2027-01-01 – 2027-06-30

Status

slate

The bar

No bar has been published for this event yet.

Verdicts

Sealed with the bar. Any verdict for this event reaches this page on 2027-07-30; subscribers get it on the day.